NCT06956222 The Effect of Hybrid Tele-rehabilitation Versus In Person Rehabilitation on Pain and Function in Patients With Knee Osteoarthritis
| NCT ID | NCT06956222 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Abdulaziz University |
| Condition | Knee Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-04-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with knee osteoarthritis often need regular physiotherapy sessions to reduce pain and improve movement. Attendance of in-person sessions can be difficult because of travel and time. This study aims to learn if combining in-person and video sessions using Zoom works for people with knee osteoarthritis. The main questions it aims to answer are : * Does combining in-person and video sessions improve pain and physical function in people with knee osteoarthritis? * Does combining in-person and video sessions improve adherence to the exercise program? * Are people satisfied with video sessions using Zoom? The researchers will compare the use of one in-person session and one video session per week to the standard care of two in-person sessions per week. Participants will : * Attend either (one in-person and one video session per week) or (two in-person sessions per week) for 8 weeks. * Perform exercise program that suits their needs during in-person and video sessions. * Record the number of attended sessions over 8 weeks. * Complete questionnaires about pain, physical function at the start and the end of the study. * Complete questionnaire about usability and satisfaction at the end of the study.
Eligibility Criteria
Inclusion Criteria: * Mild to moderate knee osteoarthritis. * Age 40 to 80 years old. * Body Mass Index \< 34 kg/m2. * Numeric pain rating scale \> 4 out of 10. * Pain for more than 3 months. * Morning stiffness lasting \< 30 minutes (standard clinical criteria of knee osteoarthritis) * Pain and crepitus with active motion (e.g., walking, sit to stand, stair climbing) (standard clinical criteria of knee osteoarthritis) * Access to the device with an internet connection. * Ability to use electronic devices or smart phones. Exclusion Criteria: * Severe knee osteoarthritis and limited mobility or bonded to a wheelchair. * Body Mass Index \> 34 kg/m2 * On a waiting list for hip or knee surgery. * Undergoing other forms of rehabilitation. * Previous knee arthroplasty. * Recent knee surgery within 6 months. * Received cortisone injection within the previous 30 days. * Rheumatoid arthritis, bilateral knee morning stiffness \> 30 minutes. * Unstable medical conditions.
Contact & Investigator
Anfal Astek
PRINCIPAL INVESTIGATOR
Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
Frequently Asked Questions
Who can join the NCT06956222 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06956222 currently recruiting?
Yes, NCT06956222 is actively recruiting participants. Contact the research team at aastek@kau.edu.sa for enrollment information.
Where is the NCT06956222 trial being conducted?
This trial is being conducted at Jeddah, Saudi Arabia.
Who is sponsoring the NCT06956222 clinical trial?
NCT06956222 is sponsored by King Abdulaziz University. The principal investigator is Anfal Astek at Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. The trial plans to enroll 60 participants.